Zum Hauptinhalt springen

Hepatitiden

05. Januar 2025 | Hepatitiden

Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort.

Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort. Harney BL, Sacks-Davis R, van Santen DK, Stewart AC, Matthews GV, Carson JM, Klein MB, Lacombe K, Wittkop L, Salmon D, Le…

04. Januar 2025 | Hepatitiden

Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome?

Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome? Tarantino G, Cataldi M, Citro V. Front Microbiol. 2024 Dec 2;15:1319897. doi: 10.3389/fmicb…

04. Dezember 2024 | Hepatitiden

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities.

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K…

22. November 2024 | Hepatitiden

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023.

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023. Maticic M, Cernosa J, Loboda C, Tamse J, Rigoni R, Duffell E…

10. November 2024 | Hepatitiden

Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program.

Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program. Choi SA, Umashankar K, Maheswaran A, Martin MT, Lee J, Odishoo M, Lin JY, Touchette DR. BMC Health Serv Res. 2024 Oct 30;24(1)…

10. November 2024 | Hepatitiden

Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.

Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study. Lopes SS, Heo M, Pericot-Valverde I, Norton BL, Taylor LE, Tsui JI, Mehta SH, Feinberg J, Kim…

10. November 2024 | Hepatitiden

Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard?

Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard? Milošević I, Filipović A, Beronja B, Mitrović N, Ružić M, Simić J, Knežević N, Pete M, Todorović N, Nikolić N. Microorga…

Weitere
akutelle Informationen
zu den Themengebieten